5KX-22920-16108
2 vaccinations
4 coded responses
16 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 407 / KY
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Moderna
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, HeadacheAdult check-in
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-14
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site warmth, Skin lesion, Type IV hypersensitivity reaction — Feeling: GoodFree text: I had a delayed hypersensitivity reaction at the site of my injection including erythema, warmth, and itchiness with satellite lesions as well beginning at day 8 and then resolving day 10 after the injection. Full diameter approx 8 cmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
-
2021-02-03
Dose 2 — Moderna
- 2021-02-03
-
2021-02-12
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: These symptoms persisted from Thursday 4-today feb 12MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 7, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Dyspnoea, Fatigue — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Non resolved sob and fatigue resulting in ekg that was abnormal. Scheduled for ECHO and Stress testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-17
Survey response — day 42, dose 2MedDRA: Chest pain, Dyspnoea, Fatigue, Myocardial infarction, Thrombosis, Vasospasm — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I had MI according to EKG done after symptoms doe, CP days 5-11 post vaccine # 2. Negative stress consistent with dissolved thrombus vs Vasospasm. Residual intermittent fatigue and dyspnea still presentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-31
- 2021-08-04
- 2022-02-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
3 call center cases
3 unsuccessful
VAERS report filed, before or during a call: 3
1 wait over 3 months for a first call
Free text
Release 2 — day 14, dose 1
Symptoms: I had a delayed hypersensitivity reaction at the site of my injection including erythema, warmth, and itchiness with satellite lesions as well beginning at day 8 and then resolving day 10 after the injection. Full diameter approx 8 cm
Release 4 — day 7, dose 2
Systemic reaction (other): These symptoms persisted from Thursday 4-today feb 12
Release 4 — day 14, dose 2
Symptoms: Non resolved sob and fatigue resulting in ekg that was abnormal. Scheduled for ECHO and Stress test
Release 5 — day 42, dose 2
Symptoms: I had MI according to EKG done after symptoms doe, CP days 5-11 post vaccine # 2. Negative stress consistent with dissolved thrombus vs Vasospasm. Residual intermittent fatigue and dyspnea still present
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Myocardial infarction | ✓ | ✓ | ✓ |
| SD | Skin lesion | ✓ | ✓ | ✓ |
| SD | Thrombosis | ✓ | ✓ | ✓ |
| SD | Type IV hypersensitivity reaction | ✓ | ✓ | ✓ |
| SD | Vasospasm | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release